Quarterly report pursuant to Section 13 or 15(d)

Organization and Summary of Significant Accounting Policies (Details Narrative)

v3.20.2
Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 9 Months Ended
Oct. 06, 2020
Sep. 30, 2020
Aug. 23, 2020
Aug. 19, 2020
May 24, 2020
Sep. 30, 2020
Sep. 30, 2019
Potentially dilutive common shares           1,146,112 662,443
Subsequent Event [Member] | Underwritten Public Offering [Member]              
Number of common stock issued during period 4,800,000            
Price per share $ 4            
Proceeds from offering $ 17,100,000            
Yuhan License Agreement [Member]              
Consideration paid       $ 2,000,000      
Consideration paid in the form of shares       500,000      
Shares issued during period, acquisition   250,000          
Elion License Agreement [Member]              
Consideration paid     $ 3,300,000        
Consideration paid in the form of shares     825,000        
Consideration paid in cash     $ 100,000        
Aposense License Agreement [Member]              
Consideration paid         $ 2,500,000    
Consideration paid in the form of shares         625,000